I know a thing or 2 and stem cell therapies require to come in from the fringe.
MSB has worked highly professionally visionary and very strategically to be far from from the fringe and to be at the forefront of registered stem cell therapeutics.
it is having a tough time with the MSC side as the little buggers are not so homogenous.
this to me leaves a cloud over the head of MSC indications given differing MOA and need for assays to prove concept and consistency might well be needed.
I do hope MSB well however the ride as a shareholder for me was less than thrilling and is a shame that such great science is marred by poor management - thus it has paid off one class action and is still facing another one.
- Forums
- ASX - By Stock
- Share price today
I know a thing or 2 and stem cell therapies require to come in...
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.16 |
Change
0.000(0.00%) |
Mkt cap ! $1.318B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 63021 | $1.24 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.10 | 11446 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 32 | 1.235 |
5 | 59868 | 1.230 |
4 | 35751 | 1.220 |
4 | 57484 | 1.210 |
2 | 52074 | 1.205 |
Price($) | Vol. | No. |
---|---|---|
1.100 | 11446 | 1 |
1.105 | 8907 | 1 |
1.120 | 190 | 1 |
1.135 | 5594 | 1 |
1.140 | 10435 | 1 |
Last trade - 10.00am 07/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.19 |
  |
Change
0.000 ( 3.40 %) |
|||
Open | High | Low | Volume | ||
$1.21 | $1.21 | $1.18 | 220561 | ||
Last updated 10.19am 07/05/2024 ? |
Featured News
MSB (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online